S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
S&P 500   4,210.24
DOW   33,309.51
QQQ   325.93
The How And Why of Investing in Oil Stocks
The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo? (Ad)
The How and Why of Investing in Gold Stocks
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
Trump says he took the Fifth in NY civil investigation
Forget Tesla, THIS Could be the Biggest EV Investment Play in 2022 (Ad)
Closing prices for crude oil, gold and other commodities
Wall Street roars after inflation cools more than expected
Rhine River could fall below critical mark, risking industry
Investors Look to Capitalize on the Budding Green Revolution (Ad)
OTCMKTS:VSMD

Vasamed - VSMD Stock Forecast, Price & News

$0.0010
0.00 (0.00%)
(As of 08/10/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range
N/A
52-Week Range
$0.00
$0.02
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VSMD stock logo

About Vasamed (OTCMKTS:VSMD) Stock

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system. It serves clinicians and patients. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota.

Receive VSMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vasamed and its competitors with MarketBeat's FREE daily newsletter.

VSMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive VSMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vasamed and its competitors with MarketBeat's FREE daily newsletter.

VSMD Company Calendar

Today
8/11/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:VSMD
CIK
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.51

Key Executives

  • Mr. Wesley G. Peterson (Age 74)
    Sec.
  • Ms. Paulita M. LaPlante (Age 64)
    VP & Director
  • Mr. Michael Schreiber
    Pres & CEO
  • Ms. Roberta L. Dircks (Age 77)
    Chief Financial Officer and VP of Fin. & Admin.
  • Mr. Daniel Bartnik
    CTO & VP of Operations













VSMD Stock - Frequently Asked Questions

How have VSMD shares performed in 2022?

Vasamed's stock was trading at $0.0010 at the start of the year. Since then, VSMD shares have increased by 0.0% and is now trading at $0.0010.
View the best growth stocks for 2022 here
.

What is Vasamed's stock symbol?

Vasamed trades on the OTCMKTS under the ticker symbol "VSMD."

How do I buy shares of Vasamed?

Shares of VSMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vasamed's stock price today?

One share of VSMD stock can currently be purchased for approximately $0.00.

How can I contact Vasamed?

Vasamed's mailing address is 7615 GOLDEN TRIANGLE DRIVE STE A, EDEN PRARIE MN, 55344. The official website for the company is www.vasamed.com. The company can be reached via phone at (952) 944-5857 or via fax at 952-944-6022.

This page (OTCMKTS:VSMD) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.